• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Other Diseases
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Other Diseases
    • View Item
    Apr 22, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Iwamoto et al - 2018 - Field ...
    Size:
    758.0Kb
    Format:
    PDF
    Download
    Authors
    Iwamoto, M
    Calzia, A
    Dublineau, A
    Rouet, F
    Nouhin, J
    Yann, S
    Pin, S
    Sun, C
    Sann, K
    Dimanche, C
    Lastrucci, C
    Coulborn, R
    Maman, D
    Dousset, JP
    Loarec, A
    Show allShow less
    Issue Date
    2018-12-03
    Submitted date
    2019-02-15
    
    Metadata
    Show full item record
    Journal
    Journal of Viral Hepatitis
    Abstract
    GeneXpert® (Cepheid) is the only WHO prequalified platform for hepatitis C virus (HCV) nucleic acid amplification testing that is suitable for point-of-care use in resource-limited contexts. However, its application is constrained by the lack of evidence on genotype 6 (GT6) HCV. We evaluated its field performance among a patient population in Cambodia predominantly infected with GT6. Between August and September 2017, we tested plasma samples obtained from consenting patients at Médecins Sans Frontières' HCV clinic at Preah Kossamak Hospital for HCV viral load (VL) using GeneXpert® and compared its results to those obtained using COBAS® AmpliPrep/Cobas® TaqMan® HCV Quantitative Test, v2.0 (Roche) at the Institut Pasteur du Cambodge. Among 769 patients, 77% of the seropositive patients (n = 454/590) had detectable and quantifiable VL using Roche and 43% (n = 195/454) were GT6. The sensitivity and specificity of GeneXpert® against Roche were 100% (95% CI 99.2, 100.0) and 98.5% (95% CI 94.8, 99.8). The mean VL difference was -0.01 (95% CI -0.05, 0.02) log10  IU/mL for 454 samples quantifiable on Roche and -0.07 (95% CI -0.12, -0.02) log10  IU/mL for GT6 (n = 195). The limit of agreement (LOA) was -0.76 to 0.73 log10  IU/mL for all GTs and -0.76 to 0.62 log10 IU/mL for GT6. Twenty-nine GeneXpert® results were outside the LOA. Frequency of error and the median turnaround time (TAT) for GeneXpert® were 1% and 0 days (4 days using Roche). We demonstrated that the GeneXpert® HCV assay has good sensitivity, specificity, quantitative agreement, and TAT in a real-world, resource-limited clinical setting among GT6 HCV patients.
    Publisher
    Wiley-Blackwell
    URI
    http://hdl.handle.net/10144/619344
    DOI
    10.1111/jvh.13002
    PubMed ID
    30199587
    Language
    en
    ISSN
    1365-2893
    ae974a485f413a2113503eed53cd6c53
    10.1111/jvh.13002
    Scopus Count
    Collections
    Other Diseases

    entitlement

    Related articles

    • Diagnosis and monitoring of HCV infection using the cobas<sup>®</sup> HCV test for use on the cobas<sup>®</sup> 6800/8800 systems.
    • Authors: Yao JD, Young S, Heilek GM, Marino E, Paxinos EE, Marins EG, Valsamakis A
    • Issue date: 2018 May
    • Analytical and field evaluation of the Biocentric Generic HCV assay on open polyvalent PCR platforms in France and Cambodia.
    • Authors: Nouhin J, Bollore K, Castera-Guy J, Prak S, Heng S, Kerleguer A, Rubbo PA, Rouet F, Tuaillon E
    • Issue date: 2018 Nov
    • Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection.
    • Authors: Bregenzer A, Warmann N, Ottiger C, Fux CA
    • Issue date: 2019 Oct 7
    • Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
    • Authors: Worlock A, Blair D, Hunsicker M, Le-Nguyen T, Motta C, Nguyen C, Papachristou E, Pham J, Williams A, Vi M, Vinluan B, Hatzakis A
    • Issue date: 2017 Apr 4
    • Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    • Authors: Pierce VM, Eversley JS, Tran TK, Rosenberg ES
    • Issue date: 2017 Jun 27
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.